Enna S J
Department of Pharmacology, Toxicology and Therapeutics, Kansas University School of Medicine, 3901 Rainbow Blvd., Kansas City, Kansas 66160, USA.
Mol Interv. 2001 Oct;1(4):208-18.
The classification of neurotransmitter receptors into distinct pharmacological subtypes is of major importance in drug discovery. This quest is particularly important for neurotransmitter systems that are widely distributed. Because gamma-aminobutyric acid (GABA) receptors, both GABA(A) and GABA(B), are found throughout the neuroaxis, they are likely involved in all central nervous system functions. Accordingly, the therapeutic promise of GABA(B) receptor manipulation depends upon the identification of subtypes than can be specifically targeted.
将神经递质受体分类为不同的药理学亚型在药物研发中至关重要。对于广泛分布的神经递质系统而言,这一探索尤为重要。由于γ-氨基丁酸(GABA)受体,即GABA(A)和GABA(B)受体,在整个神经轴中均有发现,它们可能参与了所有中枢神经系统功能。因此,操纵GABA(B)受体的治疗前景取决于能否识别出可被特异性靶向的亚型。